BRIEF-Abbott says committed to its established pharmaceuticals business

Thu May 8, 2014 9:53am EDT

May 8 (Reuters) - Abbott Laboratories : * Company CFO, speaking at Deutsche Bank Healthcare conference: * Says may be interested in geographically expanding medical device business * CFO says established pharmaceuticals (branded generics) remain a core company

business * CFO says established pharmaceuticals business is a "fundamental leg" of

company because of abbott's focus on emerging markets * CFO says company remains committed to established pharmaceuticals business * CFO says price austerity by European regulators regarding branded generics is

"dissipating" * CFO says company's diabetes business could get boost from non-invasive

glucose monitoring devices

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.